Vanguard Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $196M | Buy |
6,205,256
+41,364
| +0.7% | +$1.3M | ﹤0.01% | 1507 |
|
|
2025
Q1 | $202M | Buy |
6,163,892
+13,133
| +0.2% | +$430K | ﹤0.01% | 1483 |
|
|
2024
Q4 | $222M | Buy |
6,150,759
+22,852
| +0.4% | +$826K | ﹤0.01% | 1495 |
|
|
2024
Q3 | $191M | Sell |
6,127,907
-9,634
| -0.2% | -$300K | ﹤0.01% | 1567 |
|
|
2024
Q2 | $164M | Sell |
6,137,541
-69,273
| -1% | -$1.85M | ﹤0.01% | 1596 |
|
|
2024
Q1 | $212M | Sell |
6,206,814
-7,917
| -0.1% | -$270K | ﹤0.01% | 1482 |
|
|
2023
Q4 | $180M | Buy |
6,214,731
+142,551
| +2% | +$4.13M | ﹤0.01% | 1569 |
|
|
2023
Q3 | $167M | Buy |
6,072,180
+28,711
| +0.5% | +$792K | ﹤0.01% | 1527 |
|
|
2023
Q2 | $182M | Buy |
6,043,469
+162,404
| +3% | +$4.88M | ﹤0.01% | 1512 |
|
|
2023
Q1 | $213M | Buy |
5,881,065
+91,105
| +2% | +$3.3M | 0.01% | 1416 |
|
|
2022
Q4 | $207M | Buy |
5,789,960
+109,718
| +2% | +$3.91M | 0.01% | 1412 |
|
|
2022
Q3 | $192M | Buy |
5,680,242
+59,794
| +1% | +$2.02M | 0.01% | 1411 |
|
|
2022
Q2 | $163M | Buy |
5,620,448
+81,628
| +1% | +$2.36M | ﹤0.01% | 1555 |
|
|
2022
Q1 | $179M | Buy |
5,538,820
+25,671
| +0.5% | +$830K | ﹤0.01% | 1618 |
|
|
2021
Q4 | $161M | Buy |
5,513,149
+35,406
| +0.6% | +$1.03M | ﹤0.01% | 1725 |
|
|
2021
Q3 | $146M | Sell |
5,477,743
-6,681
| -0.1% | -$178K | ﹤0.01% | 1775 |
|
|
2021
Q2 | $169M | Buy |
5,484,424
+29,869
| +0.5% | +$920K | ﹤0.01% | 1724 |
|
|
2021
Q1 | $143M | Buy |
5,454,555
+156,477
| +3% | +$4.1M | ﹤0.01% | 1765 |
|
|
2020
Q4 | $133M | Buy |
5,298,078
+88,338
| +2% | +$2.22M | ﹤0.01% | 1686 |
|
|
2020
Q3 | $109M | Sell |
5,209,740
-212,278
| -4% | -$4.42M | ﹤0.01% | 1648 |
|
|
2020
Q2 | $129M | Sell |
5,422,018
-41,461
| -0.8% | -$985K | ﹤0.01% | 1545 |
|
|
2020
Q1 | $98.3M | Buy |
5,463,479
+157,590
| +3% | +$2.84M | ﹤0.01% | 1537 |
|
|
2019
Q4 | $126M | Sell |
5,305,889
-76,826
| -1% | -$1.82M | ﹤0.01% | 1647 |
|
|
2019
Q3 | $148M | Buy |
5,382,715
+37,498
| +0.7% | +$1.03M | 0.01% | 1513 |
|
|
2019
Q2 | $177M | Buy |
5,345,217
+49,676
| +0.9% | +$1.64M | 0.01% | 1433 |
|
|
2019
Q1 | $186M | Buy |
5,295,541
+57,479
| +1% | +$2.01M | 0.01% | 1392 |
|
|
2018
Q4 | $174M | Buy |
5,238,062
+121,584
| +2% | +$4.04M | 0.01% | 1327 |
|
|
2018
Q3 | $258M | Buy |
5,116,478
+160,765
| +3% | +$8.09M | 0.01% | 1216 |
|
|
2018
Q2 | $297M | Buy |
4,955,713
+170,631
| +4% | +$10.2M | 0.01% | 1083 |
|
|
2018
Q1 | $219M | Buy |
4,785,082
+202,986
| +4% | +$9.3M | 0.01% | 1225 |
|
|
2017
Q4 | $183M | Buy |
4,582,096
+93,032
| +2% | +$3.71M | 0.01% | 1363 |
|
|
2017
Q3 | $180M | Buy |
4,489,064
+988,529
| +28% | +$39.5M | 0.01% | 1348 |
|
|
2017
Q2 | $151M | Buy |
3,500,535
+984,200
| +39% | +$42.4M | 0.01% | 1423 |
|
|
2017
Q1 | $78.8M | Buy |
2,516,335
+156,094
| +7% | +$4.89M | ﹤0.01% | 1782 |
|
|
2016
Q4 | $59.6M | Buy |
2,360,241
+157,698
| +7% | +$3.98M | ﹤0.01% | 1881 |
|
|
2016
Q3 | $54.5M | Buy |
2,202,543
+246,067
| +13% | +$6.09M | ﹤0.01% | 1889 |
|
|
2016
Q2 | $39.9M | Buy |
1,956,476
+177,648
| +10% | +$3.62M | ﹤0.01% | 2006 |
|
|
2016
Q1 | $27.1M | Buy |
1,778,828
+58,662
| +3% | +$895K | ﹤0.01% | 2158 |
|
|
2015
Q4 | $23.1M | Buy |
1,720,166
+293,470
| +21% | +$3.94M | ﹤0.01% | 2246 |
|
|
2015
Q3 | $20M | Buy |
1,426,696
+120,967
| +9% | +$1.7M | ﹤0.01% | 2291 |
|
|
2015
Q2 | $22.2M | Buy |
1,305,729
+420,100
| +47% | +$7.13M | ﹤0.01% | 2308 |
|
|
2015
Q1 | $10.7M | Buy |
885,629
+64,120
| +8% | +$775K | ﹤0.01% | 2619 |
|
|
2014
Q4 | $6.82M | Buy |
821,509
+48,589
| +6% | +$403K | ﹤0.01% | 2727 |
|
|
2014
Q3 | $6.72M | Buy |
772,920
+115,085
| +17% | +$1M | ﹤0.01% | 2686 |
|
|
2014
Q2 | $7.2M | Buy |
657,835
+129,274
| +24% | +$1.42M | ﹤0.01% | 2667 |
|
|
2014
Q1 | $4.73M | Buy |
528,561
+123,904
| +31% | +$1.11M | ﹤0.01% | 2859 |
|
|
2013
Q4 | $3.05M | Buy |
404,657
+48,465
| +14% | +$366K | ﹤0.01% | 3024 |
|
|
2013
Q3 | $2.61M | Buy |
356,192
+3,309
| +0.9% | +$24.3K | ﹤0.01% | 3033 |
|
|
2013
Q2 | $2.27M | Buy |
+352,883
| New | +$2.27M | ﹤0.01% | 3019 |
|